Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Select Medical Holdings (SEM) EBIT Margin: 2009-2024

Historic EBIT Margin for Select Medical Holdings (SEM) over the last 16 years, with FY2024 value amounting to 5.17%.

  • Select Medical Holdings' EBIT Margin rose 10300.0% to 5.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.46%, marking a year-over-year increase of 40100.0%. This contributed to the annual value of 5.17% for FY2024, which is 3600.0% down from last year.
  • Latest data reveals that Select Medical Holdings reported EBIT Margin of 5.17% as of FY2024, which was down 3600.0% from 5.54% recorded in FY2023.
  • In the past 5 years, Select Medical Holdings' EBIT Margin registered a high of 11.5% during FY2021, and its lowest value of 3.14% during FY2022.
  • Moreover, its 5-year median value for EBIT Margin was 5.54% (2023), whereas its average is 7.12%.
  • Its EBIT Margin has fluctuated over the past 5 years, first plummeted by -83600bps in 2022, then skyrocketed by 24000bps in 2023.
  • Over the past 5 years, Select Medical Holdings' EBIT Margin (Annual) stood at 10.26% in 2020, then increased by 12bps to 11.5% in 2021, then tumbled by -73bps to 3.14% in 2022, then soared by 76bps to 5.54% in 2023, then dropped by -7bps to 5.17% in 2024.
  • Its EBIT Margin stands at 5.17% for FY2024, versus 5.54% for FY2023 and 3.14% for FY2022.